Predictive Model for Identifying Fibrotic Interstitial Lung Abnormalities on Computed Tomography for Respiratory Specialists

Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, Kodai Kawamura, Yuko Yasuda, Keisuke Anan, Zentaro Saito, Hiroko Okabayashi, Kimitaka Akaike, Noritaka Higashi, Takeshi Johkoh, Kiminori Fujimoto, Koutarou Matsumoto, Tetsuo Saito, Minoru Yoshida, Katsuhiko Mitsuzaki, Takuro Sakagami
Respirology · Wiley · 2026-10-08 · DOI: 10.1002/resp.70330

Abstract

ABSTRACT Background and Objective Interstitial lung abnormalities (ILAs) are often unreported, and fibrotic ILAs carry a worse prognosis. In this study, we aimed to develop and validate a prediction model for fibrotic ILAs using non‐radiological factors. Methods Using data from the Kumamoto ILA study (a multicenter prospective cohort in Japan), we developed a four‐variable model (age, pack‐years, fine crackles, elevated serum surfactant protein‐D) in 164 patients (2022–2023, derivation cohort) and temporally validated it in 207 patients (2023–2024, validation cohort), with internal‐external cross‐validation for between‐center heterogeneity. A simplified integer score was similarly assessed against 24‐month functional decline and treatment initiation within 3 years. Results Fibrotic ILAs comprised 82% of cases (approximately 60% subsequently met ATS‐defined ILD criteria), consistent across cohorts. The four‐variable model achieved an AUC of 0.79 (derivation) and 0.76 (validation; pooled 0.76, 95% CI 0.68–0.82), with good calibration and minimal between‐center heterogeneity. The integer score performed similarly (AUC 0.79/0.75) and correlated with functional decline (%FVC ≥ 10% or %DLco ≥ 15%) and treatment initiation. Conclusion Age, smoking exposure, fine crackles, and elevated serum surfactant protein‐D are key predictors of progressive fibrotic ILAs, supporting early risk stratification and clinical decision‐making. Trial Registration UMIN000045149/2021.12.1

Read at publisher →

Similar articles